About TPMI
Partner Hospitals
The Leadership
Access To Data
中文
The Taiwan Precision Medicine Initiative: A Cohort for Large-Scale Studies. Yang et al. BioRxiv (Oct 14, 2024)
Population-Specific Polygenic Risk Scores Developed for the Han Chinese. Chen et al. medRxiv (Oct 14, 2024)
Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort. Wei et al. medRxiv (Oct 15, 2024)
Deleterious Variants Contribute Minimal Excess Risk in Large-Scale Testing. Huang et al. medRxiv (Oct 21, 2024)